(Q38000380)

26 August 2017

Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited (English)

1 reference

26 August 2017

1 reference

Stephen W Schaffer

1

1 reference

PubMed ID

22480621

26 August 2017

Chian Ju Jong

series ordinal

2

1 reference

PubMed ID

22480621

26 August 2017

Mahmood Mozaffari

series ordinal

3

1 reference

26 August 2017

27 March 2012

1 reference

26 August 2017

Vascular Pharmacology

1 reference

26 August 2017

57

1 reference

26 August 2017

5-6

1 reference

26 August 2017

139-149

1 reference

How hyperglycemia promotes atherosclerosis: molecular mechanisms

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Biochemistry and molecular cell biology of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Oxidative stress and diabetic cardiomyopathy: a brief review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Glucose lowers the threshold for human aortic vascular smooth muscle cell migration: inhibition by protein phosphatase-2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Subapoptogenic oxidative stress strongly increases the activity of the glycolytic key enzyme glyceraldehyde 3-phosphate dehydrogenase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Nitric oxide and vascular responses in Type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

S-glutathionylation uncouples eNOS and regulates its cellular and vascular function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

H2O2-induced block of glycolysis as an active ADP-ribosylation reaction protecting cells from apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Mitochondria and vascular pathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Hyperglycemia increases mitochondrial superoxide in retina and retinal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Sulfaphenazole treatment restores endothelium-dependent vasodilation in diabetic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

The role of protein kinase C activation and the vascular complications of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

RAGE, vascular tone and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Reactive oxygen species and endothelial function in diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Oxidative stress and cardiovascular disease: novel tools give (free) radical insight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Cytochrome P450 epoxygenases and vascular tone: novel role for HMG-CoA reductase inhibitors in the regulation of CYP 2C expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Nitric oxide and oxidative stress in vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Nitric oxide synthases: regulation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Oxidative stress and vascular remodelling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Oxidative stress and diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

GAPDH as a sensor of NO stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Rapid 'glycaemic swings' induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Translocation of Glomerular p47phox and p67phox by Protein Kinase C-β Activation Is Required for Oxidative Stress in Diabetic Nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

NAD(P)H oxidase participates in the signaling events in high glucose-induced proliferation of vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Glucose down-regulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Glyceraldehyde-3-phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Advanced glycosylation end-products and NO-dependent vasodilation in renal afferent arterioles from diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

ATVB in focus: redox mechanisms in blood vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Nitric oxide, NAD(P)H oxidase, and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Myocardial utilization of carbohydrate and lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Impact of mitochondrial ROS production on diabetic vascular complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Hyperglycemia decreases mitochondrial function: the regulatory role of mitochondrial biogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

An ROS generator, antimycin A, inhibits the growth of HeLa cells via apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Inflammation in atherosclerosis and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Peroxynitrite reactions and formation in mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

NADPH oxidase and endothelial cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Detection and characterization of peroxynitrite-induced modifications of tyrosine, tryptophan, and methionine residues by tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Advanced glycation and endothelial functions: a link towards vascular complications in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Carbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Regulation of energy substrate metabolism in the diabetic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Aryl hydrocarbon receptor (AhR)-mediated induction of xanthine oxidase/xanthine dehydrogenase activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Multiple pathways of peroxynitrite cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Adaptation and maladaptation of the heart in diabetes: Part I: general concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Chronic exposure to high glucose impairs bradykinin-stimulated nitric oxide production by interfering with the phospholipase-C-implicated signalling pathway in endothelial cells: evidence for the involvement of protein kinase C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

High glucose impairs EDHF-mediated dilation of coronary arterioles via reduced cytochrome P450 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Mitochondrial formation of reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Endothelial dysfunction and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

The nitrated proteome in heart mitochondria of the db/db mouse model: characterization of nitrated tyrosine residues in SCOT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Oxidative stress and stress signaling: menace of diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Combined effects of streptozotocin-induced diabetes plus 4-methylpyrazole treatment on rat liver cytochrome P4502E1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Endothelial cells negatively modulate reactive oxygen species generation in vascular smooth muscle cells: role of thioredoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis, and restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Cysteine-674 oxidation and degradation of sarcoplasmic reticulum Ca(2+) ATPase in diabetic pig aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Expression and induction of cytochromes p450 in rat white adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.005

10.1016/J.VPH.2012.03.005

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22480621